Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recruiting Phase 1 Trials for Palbociclib (DB09073)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02255461Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsTreatment